Results 1 to 10 of about 69,415 (156)

Hidden Drug Rash With Eosinophilia and Systemic Symptoms (DRESS): A Rare Case of Preceding Organ Damage Before Skin Manifestations. [PDF]

Clin Case Rep
Sato K, Kawaguchi S, Nakajima S, Tampo A, Okada M.   +4 more
europepmc   +1 more source

Cross-Reactivity and Cross-Intolerance Among Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Clinical Patterns, COX-1-Mediated Mechanisms, and Implications for COX-2 Inhibitors and Paracetamol. [PDF]

Int J Mol Sci
Andryszkiewicz W, Lippik M, Makieła M, Modrzyk B, Gomułka K.   +4 more
europepmc   +1 more source

A Real-World Pharmacovigilance Analysis of the Safety Profiles Associated with Anti-MRSA Agents Using the Japanese Adverse Drug Event Report (JADER) Database. [PDF]

Infect Dis Rep
Hanai Y, Uekusa S, Mori M, Shimoyama K, Ohashi H, Nishimura K, Yanagino S, Matsumoto T, Matsuo K.   +8 more
europepmc   +1 more source

Cutaneous Symptoms of Cystic Fibrosis: A Narrative Review. [PDF]

Clin Cosmet Investig Dermatol
Piątkiewicz M, Olędzka B, Wołkowicz A, Durmaj A, Rudnicka L.   +4 more
europepmc   +1 more source

Antiepileptic Drug Hypersensitivity Syndrome

Epilepsia, 1998
Summary: : The antiepileptic drug hypersensitivity syndrome (AHS) is an adverse drug reaction associated with the aromatic antiepileptic drugs (AEDs) phenytoin (PHT), carbamazepine (CBZ), phenobarbital (PB), and primidone. The syndrome is defined by the triad of fever, skin rash, and internal organ involvement.
Neil H Shear
exaly   +3 more sources

Two cases of tuberculosis with multiple drug hypersensitivity after drug-induced hypersensitivity syndrome

Respiratory Investigation, 2012
Here, we report 2 cases of drug-induced hypersensitivity syndrome (DIHS) caused by salazosulfapyridine and allopurinol during tuberculosis treatment. Both patients also developed multiple drug hypersensitivity (MDH) to several antituberculosis drugs that were used at around the period of DIHS onset, and thus, the treatment could not be successfully ...
Akimasa Sekine, Takefumi Saito, Shusaku Itô   +2 more
exaly   +3 more sources

Multiple drug hypersensitivity syndrome

Current Opinion in Allergy & Clinical Immunology, 2013
The multiple drug hypersensitivity syndrome (MDH) is a distinct clinical entity, different from cross-reactivity and flare-up reactions. Following its initial description in 1989 by Sullivan et al., several authors have addressed the issues surrounding this peculiar form of drug hypersensitivity.
Anca M, Chiriac, Pascal, Demoly
openaire   +2 more sources

Drug Hypersensitivity Syndrome

Dermatology, 2009
Some types of hypersensitivity to drugs are defined either by the generic name of the drug or descriptive terms. They are sometimes assimilated to pseudolymphoma because the causative drugs are often the same, although the eruption lacks clinical and histopathological criteria of pseudolymphoma.
openaire   +2 more sources

Drug Hypersensitivity Syndrome Caused by Minocycline

Journal of Cutaneous Medicine and Surgery, 2006
Background: Minocycline is a commonly prescribed drug for the treatment of acne. Its use is generally not associated with systemic side effects. Objective: To describe a case of minocycline-induced drug hypersensitivity syndrome in a ...
Daisuke, Tsuruta, Yukiko, Someda, Junko, Sowa, Hiromi, Kobayashi, Masamitsu, Ishii   +4 more
openaire   +2 more sources

Relapsing drug-induced hypersensitivity syndrome

Current Opinion in Allergy & Clinical Immunology, 2016
Purpose of review Drug-induced hypersensitivity syndrome (DIHS) is a serious adverse drug reaction with potential morbidity and mortality. ‘Flare up’ or relapses in DIHS is a rare but important feature. These relapses may occur within days to several weeks, even after discontinuation of the offending drug.
Sze-Chin, Tan, Grace Y L, Chan
openaire   +2 more sources